0001104659-20-130008.txt : 20201127 0001104659-20-130008.hdr.sgml : 20201127 20201127160257 ACCESSION NUMBER: 0001104659-20-130008 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201117 FILED AS OF DATE: 20201127 DATE AS OF CHANGE: 20201127 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Redmile Group, LLC CENTRAL INDEX KEY: 0001425738 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36533 FILM NUMBER: 201355326 BUSINESS ADDRESS: STREET 1: ONE LETTERMAN DRIVE STREET 2: BUILDING D, SUITE D3-300 CITY: SAN FRANCISCO STATE: CA ZIP: 94129 BUSINESS PHONE: 415-489-9980 MAIL ADDRESS: STREET 1: ONE LETTERMAN DRIVE STREET 2: BUILDING D, SUITE D3-300 CITY: SAN FRANCISCO STATE: CA ZIP: 94129 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Green Jeremy CENTRAL INDEX KEY: 0001650527 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36533 FILM NUMBER: 201355327 MAIL ADDRESS: STREET 1: ONE LETTERMAN DRIVE, BUILDING D STREET 2: SUITE D3-300 CITY: SAN FRANCISCO STATE: CA ZIP: 94129 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MedAvail Holdings, Inc. CENTRAL INDEX KEY: 0001402479 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 900772394 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6665 MILLCREEK DR STREET 2: UNIT 1 CITY: MISSISSAUGA STATE: A6 ZIP: L5N 5M4 BUSINESS PHONE: 973-509-0444 MAIL ADDRESS: STREET 1: 6665 MILLCREEK DR STREET 2: UNIT 1 CITY: MISSISSAUGA STATE: A6 ZIP: L5N 5M4 FORMER COMPANY: FORMER CONFORMED NAME: MYOS RENS TECHNOLOGY INC. DATE OF NAME CHANGE: 20160322 FORMER COMPANY: FORMER CONFORMED NAME: MYOS Corp DATE OF NAME CHANGE: 20120521 FORMER COMPANY: FORMER CONFORMED NAME: Atlas Therapeutics Corp DATE OF NAME CHANGE: 20100719 3 1 tm2037152d-1_3.xml OWNERSHIP DOCUMENT X0206 3 2020-11-17 0 0001402479 MedAvail Holdings, Inc. MDVL 0001425738 Redmile Group, LLC ONE LETTERMAN DRIVE, BUILDING D SUITE D3-300 SAN FRANCISCO CA 94129 1 0 1 0 0001650527 Green Jeremy ONE LETTERMAN DRIVE, BUILDING D SUITE D3-300 SAN FRANCISCO CA 94129 1 0 1 0 Common Stock 11724726 I See Footnote Warrants to Purchase Shares of Common Stock 2.09 2019-03-04 2029-03-04 Common Stock 73253 I See Footnote Warrants to Purchase Shares of Common Stock 2.09 2019-07-23 2029-07-23 Common Stock 87058 I See Footnote Warrants to Purchase Shares of Common Stock 1.57 2019-12-19 2029-12-19 Common Stock 54524 I See Footnote Warrants to Purchase Shares of Common Stock 1.57 2020-05-26 2030-05-26 Common Stock 74855 I See Footnote Warrants to Purchase Shares of Common Stock 1.57 2020-10-06 2030-10-06 Common Stock 15236 I See Footnote These securities are directly owned by certain private investment vehicles and separately managed accounts managed by Redmile Group, LLC ("Redmile") and may be deemed beneficially owned by Redmile as investment manager of such private investment vehicles and separately managed accounts. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Gerard van Hamel Platerink and Rob Faulkner, members of the board of directors of the Issuer and managing directors of Redmile, were elected to the board of the Issuer as representatives of Redmile. As a result, the Reporting Persons are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934, as amended. The exercise price for the warrant is in Canadian dollars. By: /s/ Jeremy Green, Managing Member of Redmile Group, LLC 2020-11-27 /s/ Jeremy Green 2020-11-27